What does each one actually do?
They get mentioned in the same breath because all three touch the mitochondria, the parts of your cells that turn food into usable energy. Saying they're all mitochondrial is about as useful as saying three people all work in healthcare, because the jobs are different, and that difference is what decides the order.
Urolithin A is studied for clean-up, the process your cells use to clear out worn mitochondria so newer ones can take over. It's a capsule rather than an injection, and it has more randomized human trials behind it than the other two. SS-31, also called elamipretide, is studied for steadying the inner membrane of the mitochondria you already have, more tune-up than replacement. MOTS-c is a different kind of tool again, studied for how your body uses blood sugar and burns fat.
Clear the old ones out, steady what's left, and tell the body how to spend its fuel. On paper that's a tidy division of labor, which is exactly why people buy all three in the same cart.
Urolithin A first
A capsule with the cleanest safety record of the three, treated as background rather than an event.
SS-31 second
Once urolithin A has settled in and nothing else in your routine is shifting.
MOTS-c only if the markers fit
Check fasting insulin and HbA1c first. If your blood sugar markers are already healthy, it may be aimed at something you don't have.
Why not start all three at once?
Nobody has tested the three together in people, and each one on its own has a modest effect. Put those two facts side by side and starting them in the same month means that if you feel better, you've got three suspects and no way to question them. You keep buying all three just in case, which is the most expensive way to learn nothing.
That's a reading problem rather than a safety one. The same goes for anything else in your routine that's moving, like a GLP-1 dose going up or another peptide switching from a loading phase to a lower amount. Every extra change you add in the same window makes the month harder to read.
If you've just finished a course of something else, give it time to show its own effect before starting the next thing. Filling the gap straight away is the easiest way to lose the result you were waiting for.
Why does urolithin A usually go first?
It's a capsule, so it doesn't take up an injection, and it has the cleanest safety record of the three. In the human trials, people taking it for up to four months had no more side effects than people on a placebo. Those trials were short and mostly in older adults, so what years of use does isn't known.
The amounts come from those trials too. They gave 500 mg or 1,000 mg a day, and the four-month trial in older adults used 1,000 mg. No label sets a dose, and no study has compared taking it with food or without. The full rundown is on the urolithin A page.
Treat it as background rather than an event. The trials ran for up to four months, and the endurance change in older adults showed up at the two-month check, so a couple of weeks tells you very little.
It isn't sold by research peptide vendors, so it's not in our per-milligram comparison. Mitopure is the form the trials used, and all three of those trials were run with its maker. See Mitopure on Amazon. That's an affiliate link, which means we may earn a commission at no cost to you. Our affiliate policy explains what that does and doesn't buy.
When does SS-31 come in?
Second, once urolithin A has settled in and nothing else in your routine is shifting. SS-31 has human trial data of its own, run in people with specific medical conditions rather than healthy women in midlife, and what people report is mixed: some notice easier, steadier effort after several weeks, and some notice nothing. That's reported experience, not a trial finding.
It's a research vial, so it comes with mixing and a syringe. The SS-31 dosage page lays out the amounts people use, each with its source, and how far a vial goes.
Do you need MOTS-c at all?
Maybe not, and it's the one to question before buying. Its research is mostly about insulin resistance and fat gain, so it makes the most sense when that's actually your problem. If your blood sugar markers are already in a healthy range, MOTS-c may be aimed at something you don't have.
Two blood tests answer that. Fasting insulin shows how hard your body is working to keep blood sugar steady, and HbA1c reflects your average blood sugar over roughly the past three months. Ask for both before you add it, not after. IGF-1, a growth hormone marker that sometimes gets suggested here, belongs to a different conversation and doesn't help with this decision.
If the markers say it fits, the MOTS-c dosage page covers the amounts people use and where each comes from.
How will you know if any of it worked?
How you feel counts, but it's easy to fool. If you'd like something firmer, get hs-CRP, a general inflammation marker, drawn before you start anything. It's only useful as a before and after comparison, so the before has to come first. Inflammation markers were among the blood measures that came down in the urolithin A trial in older adults, which makes it a sensible one to watch.
ApoB, a cholesterol marker some doctors prefer to the standard panel, is a cheap add-on to the same draw, though it won't decide anything here. Keep your notes simple: the date you started each one, what you noticed, and when.
How do you buy them well?
Urolithin A is a supplement, so check the amount of urolithin A per serving rather than the capsule size, and work out what a day at the trial amounts costs. A cheaper capsule with half the urolithin A isn't the cheaper buy, it's just the smaller one.
SS-31 and MOTS-c come from research vendors, and the price per milligram swings more than people expect. Run both through the price comparison before you buy, and only buy from a seller who publishes third-party testing for each batch. How to tell whether a certificate of analysis is real takes about thirty seconds, and our vendor directory shows who posts them.
What nobody can promise you
No one knows whether the three add up in people, because the combination hasn't been tested. The order above is how people commonly reason through it, not a result from a study. Urolithin A's trials were short and run with the company that sells it, and the SS-31 trials were in people with specific illnesses. If energy is the broader goal, our energy page collects everything we've written on it, and what to take with NAD+ covers where these three fit next to it.
SS-31 has a label for one rare disease, MOTS-c has none, and any vial of either bought online is sold for research. You knew that, it's why you're reading this and not the label.
